The Oral Microbiome-Inflammaging Axis in Elderly Periodontitis: Emerging Immunopathogenic and Systemic Mechanisms.
Key claim: Elderly periodontitis is a geroscience-relevant disorder in which oral dysbiosis and biological aging jointly establish a self-sustaining inflammatory ecosystem that drives multi-organ frailty-like phenotypes even after local therapy.
Abstract
BACKGROUND: Periodontitis prevalence increases with age, yet “elderly periodontitis” is not merely cumulative plaque exposure. Aging remodels mucosal immunity, elevates chronic inflammation, and promotes senescent cell accumulation with pro-inflammatory secretory phenotypes. OBJECTIVE: To critically evaluate the self-reinforcing oral microbiome-inflammaging axis in elderly periodontitis. METHODS: Narrative synthesis of mechanistic studies, human cohorts, and preclinical models investigating interactions between oral microbial ecology, immunosenescence, cellular senescence, and inflammaging. RESULTS: Dysbiotic biofilms deliver persistent pressure interpreted by aged immune-stromal networks with heightened inflammatory gain. Mechanistic studies implicate aging-sensitive TLR9 sensing, age-amplified inflammasome-linked macrophage responses to P. gingivalis, and senescent niches that potentiate inflammation. Microbes directly induce senescence programs, including epithelial senescence and exosome-mediated paracrine immune senescence. Systemically, periodontitis induces multi-organ frailty-like phenotypes, neuroinflammatory changes, persistent gut dysbiosis, and altered metabolomes despite local therapy. CONCLUSION: Elderly periodontitis represents a geroscience-relevant disorder where dysbiosis and biological aging jointly establish a self-sustaining inflammatory ecosystem. Priority gaps include longitudinal elderly cohorts integrating microbiome function with senescence markers and stratified trials combining biofilm control with host modulation.
Why this matters
Elderly periodontitis is being reframed from a local dental problem into a candidate systemic aging accelerator, joining gut dysbiosis and adipose SASP on the growing list of tissue-local sources feeding inflammaging and frailty. If the axis holds, it implies that periodontal therapy alone will not extinguish the inflammatory tone once immunosenescence and gingival cellular senescence have locked in a self-reinforcing loop. The claim currently rests on narrative synthesis of preclinical and observational evidence, with no interventional test that resolving the axis alters systemic aging endpoints in humans.